Human pluripotent stem cell (hPSC) derived tissues often remain developmentally immature in vitro, and become more adult-like in their structure, cellular diversity and function following transplantation into immunocompromised mice. Previously we have demonstrated that hPSC-derived human lung organoids (HLOs) resembled human fetal lung tissue in vitro (Dye et al., 2015). Here we show that HLOs required a bioartificial microporous poly(lactide-co-glycolide) (PLG) scaffold niche for successful engraftment, long-term survival, and maturation of lung epithelium in vivo. Analysis of scaffold-grown transplanted tissue showed airway-like tissue with enhanced epithelial structure and organization compared to HLOs grown in vitro. By further comparing in vitro and in vivo grown HLOs with fetal and adult human lung tissue, we found that in vivo transplanted HLOs had improved cellular differentiation of secretory lineages that is reflective of differences between fetal and adult tissue, resulting in airway-like structures that were remarkably similar to the native adult human lung.https://doi.org/10.7554/eLife.19732.001
The past decade has seen an exciting emergence of new models of human development and disease (St Johnston, 2015). These advances stem from our ability to culture primary human tissues and derive complex three-dimensional organ-like tissues, called organoids from human pluripotent stem cells (hPSCs) (Dedhia et al., 2016; Fatehullah et al., 2016; Johnson and Hockemeyer, 2015; Huch and Koo, 2015; Rookmaaker et al., 2015; Dye et al., 2016). Both tissue-derived and hPSC-derived human lung models have been developed and recapitulate some structural and cellular features of the human lung (Barkauskas et al., 2013; Rock et al., 2009; Gotoh et al., 2014; Konishi et al., 2016; Vaughan et al., 2006; Pageau et al., 2011; Fessart et al., 2013; Franzdóttir et al., 2010; Kaisani et al., 2014; Dye et al., 2015; Firth et al., 2014; Mou et al., 2016). For example, we recently described methods to direct differentiation of hPSCs in a stepwise process, which mimicked aspects of in vivo lung development, into three-dimensional human lung organoids (HLOs). HLOs possessed closed epithelial cysts resembling airway-like structures, which consisted of epithelial cells primarily expressing ciliated and basal cell markers. The airway-like structures were surrounded by mesenchyme, including cells expressing smooth muscle and myofibroblast markers (Dye et al., 2015). Despite having airway-like organization around a lumen, the HLO epithelium was disorganized and did not possess some cell types found in the mature airway, including club and goblet secretory cell lineages. Consistent with in vitro differentiated HLOs being immature, transcriptome-wide comparisons showed that HLOs were similar to the human fetal lung (Dye et al., 2015).
In addition to HLOs, intestinal, kidney and cerebral organoids are similar to the analogous human fetal organ (Dye et al., 2015; Finkbeiner et al., 2015b; Camp et al., 2015; Takasato et al., 2015). Human intestinal organoids (HIOs), for example, are an in vitro three-dimensional model of the human intestine derived from hPSCs that closely resemble the fetal intestine. When transplanted under the mouse kidney capsule, HIOs mature and gain relevant adult structures including villi and crypts (Finkbeiner et al., 2015b; Watson et al., 2014; Finkbeiner et al., 2015a). In the current work, our goal was to transplant HLOs to determine if an in vivo environment would enhance the structural organization and cellular differentiation of the airway-like tissue.
Our results show that, unlike intestinal organoids, HLOs placed under the mouse kidney capsule, in the omentum, or the epididymal fat pad did not generate lung epithelial structures or cell types. Thus, while all of these highly vascular sites have been utilized for engraftment in other contexts (Finkbeiner et al., 2015b; Watson et al., 2014; Pepper et al., 2013; Bartholomeus et al., 2013; Smink et al., 2013), HLOs did not thrive in these environments. We turned to microporous poly(lactide-co-glycolide) (PLG) scaffolds in order to create an alternative niche for the HLOs during transplantation since PLG scaffolds have led to improved survival and function of pancreatic beta cells following transplantation (Gibly et al., 2013; Blomeier et al., 2006; Hlavaty et al., 2014; Graham et al., 2013; Kheradmand et al., 2011).
Our results demonstrate that microporous PLG scaffolds provided a niche for HLOs that enhance survival and engraftment upon transplantation into the epididymal fat pad of NOD-scid IL2Rgnull (NSG) mice. After 8–15 weeks, the retrieved transplanted HLOs (tHLOs) possessed airway-like structures with improved epithelial organization resembling the human adult lung and demonstrated enhanced cellular differentiation into basal, ciliated, club, and goblet cells. The tHLO airway structures were vascularized, and surrounded by mesenchymal cells that expressed both smooth muscle and myofibroblast markers, in addition to areas of organized cartilage. This work demonstrates that hPSC-derived lung tissue can give rise to complex multicellular airway-like structures in vivo, similar to those found in the adult human lung.
It has been shown that hPSC derived intestinal organoids acquire crypt and villus structures resembling the adult intestine along with mature cell types by transplantation into a highly vascular in vivo environment such as the kidney capsule or the abdominal omentum (Finkbeiner et al., 2015b; Watson et al., 2014). A similar strategy was employed in an attempt to engraft and mature HLOs, in which several different experimental conditions and engraftment sites were attempted utilizing NSG mice. Experiments were initially conducted using the hESC line UM63-1, and all major findings were reproduced in two additional hESC lines; H1 and H9 (Table 1). Data presented throughout the manuscript are from the hESC line UM63-1, unless otherwise stated. In our first attempt, 35d (35 day old) HLOs were placed under the kidney capsule and were harvested after 4 weeks (Figure 1—figure supplement 1A–B). The retrieved organoids expressed the human-specific mitochondria marker (huMITO), but lacked NKX2.1+ lung epithelium (Table 1, Figure 1—figure supplement 1A–C). We hypothesized that an earlier stage of HLO cultures may be more proliferative and therefore have better survival upon engraftment. 1d HLOs were injected under the kidney capsule (Table 1, Figure 1—figure supplement 1D). After 6 weeks, the tissue had expanded, surpassing the size of the kidney (Figure 1—figure supplement 1E). Further analysis demonstrated that the tissue was of human origin (huMITO+), but no NKX2.1+ epithelium was observed (Figure 1—figure supplement 1F). Thus, the age of transplanted HLOs did not seem to affect the survival of the HLO lung epithelium.
Next, we assessed the effect of the transplant site on HLO maturation. 65d HLOs were placed into the abdominal omentum and secured in place with a stitch, which also allowed us to identify the site of the transplant. Tissues were harvested after 12 weeks (Table 1, Figure 1—figure supplement 1G–H), and again were positive for huMITO, but the majority did not have evidence of a lung epithelium (Figure 1—figure supplement 1I). Only 2 of the 13 mice transplanted in this cohort demonstrated huMITO+ airway-like structures as indicated by expression of the lung epithelial marker NKX2.1, the basal cell marker P63, and the ciliated cell marker FOXJ1 (Figure 1—figure supplement 2). Taken together, these data indicated that alternative sites of transplantation did not robustly support survival or growth of the HLO lung epithelium in vivo (Table 1).
Given that we recovered human tissues that were largely devoid of lung epithelium, we hypothesized that transplantation of HLOs would be enhanced if provided a structural niche, which has been demonstrated to improve engraftment, vascularization and to support the survival of transplanted pancreatic beta cells (Gibly et al., 2013; Blomeier et al., 2006; Hlavaty et al., 2014; Graham et al., 2013; Kheradmand et al., 2011; Gibly et al., 2011). Microporous PLG scaffolds provide a rigid environment for the tissue to adhere to along with a porous (250–425 µm diameter) honeycomb-like structure to enable tissue growth and infiltration of vasculature (Figure 1A). In order to prepare PLG-HLO constructs for transplant, HLOs were suspended in Matrigel and pipetted onto the scaffolds. 1d HLOs were able to adhere to the pores on the scaffold, with the majority of the HLOs scattered across the 5 mm diameter surface, and a few towards the middle of the 2 mm thick scaffold (Figure 1B–C). HLO-seeded PLG scaffolds were subsequently cultured for 5 to 7 days in vitro submersed in 500 ng/mL FGF10 supplemented media, the same media used to grow HLOs in vitro (Dye et al., 2015) (Figure 1D). Following 5–7 days of culture, constructs were transplanted directly, or dipped in Matrigel supplemented with FGF10 (500 ng/mL) prior to transplantation. Both conditions were transplanted into the mouse epididymal fat pad (Matrigel/FGF10 n = 8; without Matrigel/FGF10 n = 4, Table 1 and Figure 1D–E). In both conditions, 100% of the recovered constructs possessed NKX2.1+ airway-like structures (n = 12 total) (Characterized in Figures 1–3, Table 1), suggesting that the addition of Matrigel/FGF10 prior to transplant was not necessary, but that the scaffold provided critical support for engraftment and survival of the lung epithelium. The epididymal fat pad was chosen as the site for transplantation because it was the only site able to accommodate the large size of the scaffold-HLO construct while still providing a highly vascular environment. As a control, 1d HLOs in a Matrigel plug (without being placed on a scaffold) were transplanted into the epididymal fat pad but no tissue was recovered at 8 weeks post-transplant (Table 1). We also demonstrated that HLOs generated from three independent hESC lines (H1, H9, UM63-1) developed similarly following transplantation on scaffolds (Table 1). Collectively, these data demonstrated that PLG scaffolds provide a robust niche, enabling HLOs to engraft and survive in the epididymal fat pad.
The Matrigel/FGF10 treated scaffold constructs were harvested at two time points, 4 weeks and 8 weeks after transplant (Table 1). After 4 weeks of transplantation, constructs had airway-like structures that resembled in vitro grown HLOs (Figure 1—figure supplement 3) (Dye et al., 2015). 4 week HLO constructs had NKX2.1 +/huMITO+ airway-like structures that consisted of cells expressing the basal cell marker P63 and ciliated markers FOXJ1 and Acetylated Tubulin (ACTTUB), but the secretory club cell marker CC10 (also known as SCGB1A1) was not detected, suggesting that 4 weeks of transplantation did not lead to enhanced structure within HLOs (Figure 1—figure supplement 4).
The scaffold-HLO constructs harvested after 8 weeks ranged in size from 0.5 cm to 1.5 cm (Figure 1F). We observed that each transplanted HLO had multiple epithelial structures per cross section. To further characterize the in vivo grown HLOs, we quantified the total number of epithelial structures (ECAD+) per cross-section and found that 86.19% of all ECAD structures were also NKX2.1+ (Figure 1G,I, Figure 1—source data 1). The histology of the transplanted tissue revealed airway-like structures tightly surrounded by mesenchymal cells. In addition, there were pockets of organized cartilage throughout the transplants (Figure 1H). Epithelial structures were verified to be of human origin using huMITO and the human-specific nuclear marker HUNU (Figure 1J–K). As a control, 1d HLOs were seeded on the scaffold and grown in vitro for 4 to 8 weeks. These in vitro grown HLO-scaffolds had significantly less growth, and although some cells expressed the lung marker NKX2.1, no airway structures were observed (Figure 1—figure supplement 5). This is possibly due to the fact that HLOs grown in vitro are normally embedded in Matrigel and passaged every two weeks whereas tissue grown on the scaffolds could not be passaged, and were not embedded in Matrigel. Thus, results from in vitro grown scaffold-HLO constructs suggest that the scaffold alone does not support long term HLO growth or induce the enhanced epithelial organization or maturation, but the combination of the scaffold and the in vivo environment allows for growth and maturation of the HLO epithelium.
The native lung is organized into airway structures and alveoli. Interestingly, even though in vitro grown HLOs possessed alveolar cell types (Dye et al., 2015), we could not find evidence for the ATI marker HOPX or the ATII marker SFTPC in tHLOs at 4 or 8 weeks indicating that these cell types do not persist in vivo (data not shown). Native lung airways are organized into a SOX2+ pseudostratified epithelium with basal and multiciliated cells being the most prevalent cell types in the airway (Mercer et al., 1994; Li et al., 2013; Morrisey and Hogan, 2010). Both non-transplanted HLOs and transplanted HLOs expressed the airway marker SOX2; however, tHLOs on scaffolds formed a highly organized pseudostratified epithelium, including taller ECAD+ cells that had a clearly visible apical and basal surface similar to the adult human airway (Figure 2A; Note that adult human airways examined are consider lower bronchi as detailed in the Materials and methods). The average cell height – from the apical to basal surface – of cells lining the tHLO airway-like lumen was similar to adult lungs while the non-transplanted HLOs grown in Matrigel had significantly shorter cells than the tHLOs and adult lungs (Figure 2B). In both fetal upper airways and adult airways, basal cells line the basal side of the airway epithelium and express markers including P63, cytokeratin 5 (CK5), and NGFR (2C-E, Figure 2—figure supplement 1A–C; Note that fetal human airways examined are considered upper bronchi, as detailed in the Materials and methods). Both non-transplanted and transplanted HLOs possessed cells lining the basal side of the airway-like structures that expressed the basal cell markers P63, CK5, and NGFR, however; basal cells in tHLOs had cellular organization and shape more reminiscent of the native human lung (Figure 2C–E).
Upon dissection of tHLOs, we observed tube-like structures within the 8 week constructs. Micro-dissected tube-like structures were stained for FOXJ1 and P63 using whole-mount immunostaining, followed by confocal imaging (Figure 2F). Whole-mount imaging revealed tube-like structures with abundant FOXJ1 and P63 expressing cells. P63+ cells appeared to line the basal surface of the tube, while FOXJ1 appeared to be located closer to the lumen. A cross section through a three-dimensional rendered airway revealed that the structure had a lumen lined by FOXJ1+ cells, while P63+ cells lined the outside of the tube along the basal side of the airway-like tissue. This organization was similar to the upper airways in the adult and fetal human lung (Figure 2F, Figure 2—figure supplement 1A–C). Although several tube-like structures were observed, micro-dissection was very disruptive, and did not allow accurate quantitation of the number of these structures. Thus, it is likely that not all airway-like structures were shaped as a tube, and cyst-shaped airway structures are also present within the transplants. In the adult airway and fetal upper airway sections, the majority of the cells facing toward the lumen express the ciliated cell marker FOXJ1 and are multiciliated, demonstrated by ACTTUB staining (Figure 2G, Figure 2—figure supplement 1B–D. In vitro grown HLOs have scattered cells that express FOXJ1 and few disorganized cells that are multiciliated as shown by ACTTUB immunofluorescence (Figure 2G, Figure 2—figure supplement 1B,D). In contrast, most of the cells facing toward the lumen in tHLOs were FOXJ1+, multiciliated as shown by ACTTUB immunofluorescence, and highly organized in a manner similar to the adult airway (Figure 2G, Figure 2—figure supplement 1B–D). In addition, microdissection of tHLO airway-like structures revealed abundant beating multiciliated cells suggesting that these cells are functional (Video 1).
In order to demonstrate variability across multiple tHLOs (n = 9 independent transplants), we quantitated the percent of all epithelial structures within tHLOs that are NKX2.1+ (Figure 1—source data 1), along with the percent of NKX2.1+ epithelial structures that also displayed improved organization and possessed differentiated cell types (Figure 2H, Figure 2—source data 1). We observed that 97.53% of all NKX2.1+ airway-like structures in the tHLOs possessed abundant multiciliated cells, as determined by ACTTUB immunofluorescence (Figure 2H, Figure 2—source data 1). This finding is consistent with data demonstrating that multiciliated cells are the most abundant cell type within human adult airway epithelium (Mercer et al., 1994).
The secretory cells of the lung, goblet and club cells, are fewer in number and are scattered throughout mature human airways (Figure 3A–B) (Mercer et al., 1994). We had previously reported that HLOs grown in vitro possessed rare cells expressing low levels of the club cell marker CC10 and we did not detect cells expressing MUC5AC protein, which is found in goblet cells (Dye et al., 2015). We asked if the lack of differentiated secretory cell types reflected an immature stage of development by comparing cellular differentiation in human adult and fetal airways. In adult airways, cells expressing the club cell markers CC10 and PLUNC and cells expressing the goblet cell marker MUC5AC were scattered throughout the airway (Figure 3A–B, Figure 3—figure supplement 1). In contrast, we could not find evidence for robust expression of any of these markers in the human fetal lung at 14 weeks of gestation (Figure 3A–B, Figure 3—figure supplement 1). Similar to the adult airway, we observed that the tHLO epithelium had distinct CC10+, PLUNC+, and MUC5AC+ cells (Figure 3C–E). Further quantification of secretory cells in multiple tHLOs (n = 9 independent transplants) revealed biological heterogeneity across samples. On average 45.55% of all NKX2.1+ airways contained CC10+ secretory cells and 70.43% contained MUC5AC+ secreting cells, however; variability ranged from some individual tHLOs possessing no secretory cells (n = 2/9 possessed no CC10+; n = 1/9 possessed no MUC5AC+) to 100% of all airway structures within an individual tHLO possessing secretory cell types (n = 1/9 CC10+; n = 3/9 MUC5AC+) (Figure 2H, Figure 2—source data 1). Highly organized airway-like structures with multiple cell types (P63+ basal, ACTTUB+ multiciliated, CC10+ club and MUC5AC+ goblet cells) were also observed in tHLOs derived from the H9 and H1 cell lines, indicating that maturation of airway-like structures upon transplantation is reproducible across multiple cell lines (Figure 3—figure supplement 2). Moreover, airway-like structures transplanted for different lengths of times (8 weeks, 15 weeks) appeared similar in epithelial organization and in expression of mature airway markers (Figure 3—figure supplement 2). Taken together, our data demonstrate that in vivo grown tHLOs possess airway-like epithelium with basal, ciliated, goblet, and club cells in a highly organized pseudostratified epithelium that resembled both the structure and cellular diversity of adult human airways.
Along with the epithelium, native adult airways are surrounded by smooth muscle, myofibroblasts, and cartilage. The tHLO airway structures were surrounded by cells expressing both smooth muscle actin (SMA) and PDGFRα positive (SMA+/PDGFRα+) along with SMA+PDGFRα- cells (Figure 4A), which are markers for myofibroblasts and smooth muscle respectively (Boucherat et al., 2007; Hinz et al., 2007; Chen et al., 2012). We have previously reported that HLOs grown in vitro did not possess cartilage (Dye et al., 2015). Consistent with these previous findings, cartilage was not present in control scaffolds seeded with HLOs and grown in vitro, as shown by the absence of SafraninO staining (Figure 4B). Interestingly, tHLOs possessed areas of organized cartilage indicated by cell morphology and staining for SafraninO (Figure 1H, Figure 4B). Cartilage within the tHLOs expressed the cartilage marker SOX9, along with the human mitochondrial marker, huMITO, indicating that the cartilage was derived from the transplanted tissue (Figure 4—figure supplement 1A). Further analysis of in vitro grown HLOs revealed that there were areas of SOX9+ mesenchyme, suggesting that a putative population of cartilage precursors is present in the HLOs grown in vitro (Figure 4—figure supplement 1B).
Finally, upon gross inspection of tHLOs, we observed abundant vasculature associated with the tissue, an observation that is consistent with transplanted human intestinal organoids (Watson et al., 2014).
To date, several groups have derived two and three-dimensional lung models from both primary human lung tissue and from hPSCs that consist of airway epithelial cell types (Barkauskas et al., 2013; Rock et al., 2009; Gotoh et al., 2014; Konishi et al., 2016; Dye et al., 2015; Firth et al., 2014; Mou et al., 2016; Wong et al., 2012; Huang et al., 2013). Tissue grown on an air-liquid interface generated an organized pseudostratified epithelium that reflects most of the cellular diversity of the human airway (Mou et al., 2016; Wong et al., 2012), while other models possess an airway epithelium with a supporting mesenchyme (Firth et al., 2014). Previous work has also shown that lung epithelial cells derived from hPSC monolayers transplanted underneath a mouse kidney capsule can further differentiate into cells expressing airway and alveolar markers over a period of six months (Huang et al., 2013). However, it was unclear how robust this approach was, and whether this yielded tissue with any degree of organization. To our knowledge, the work presented here is the first to show that hPSC-derived HLOs are able to engraft in vivo and differentiate into an organized pseudostratified airway-like epithelium with a complete repertoire of airway cell types and supporting mesenchyme, along with a vascular supply and the ability to survive for long periods of time. Interestingly, our findings demonstrated that despite the fact that in vitro grown HLOs possessed alveolar cell types, we found no evidence of alveolar cells or alveolar structure in tHLOs. Given that the alveolar cell types present in HLOs were few in number, it is possible that these cells were not abundant enough to persist in vitro, or alternatively, that PLG scaffolds did not promote their survival. Ongoing studies are aimed at better understanding how to generate these distal airway structures.
Here, we used microporous PLG scaffolds to provide a physical environment for HLO engraftment in vivo however; alternative engineering approaches have also been developed as a platform to grow organized lung-like structures. For example, decelluarized lung scaffolds have been employed to seed primary and derived lung tissue in order to provide an appropriate physical and structural environment and in attempts to generate lung-like tissue (Dye et al., 2015; Gilpin et al., 2014, 2016; Booth et al., 2012; Ghaedi et al., 2014). Many efforts have focused on seeding alveolar tissue including alveolar type I and II cells onto acellular matrices (Gilpin et al., 2014; Booth et al., 2012; Ghaedi et al., 2014), and lung tissue derived from mouse embryonic stem cells seeded on decellularized rat lung matrix enhanced maturation of airway cell types and epithelial organization (Shojaie et al., 2015). Our data previously demonstrated that in vitro grown HLOs seeded onto an adult human decelluarized lung matrix allowed adherence of the HLO epithelium to the airway matrix and resulted in the differentiation of a small number of multiciliated cells, but did not enhance club or goblet cell differentiation (Dye et al., 2015). Collectively, our data along with the data from decelluarized lung scaffolds suggest that providing an ideal physical environment may be an important factor for promoting tissue organization and differentiation, but that additional cues will also be required for full tissue maturation.
Recent breakthroughs in biomimetic microfluidic cell-culture devices called 'organs on a chip' have also generated airway epithelium from human adult airway cells grown on an air-liquid interface platform. The microfluidic devices allow are designed to mimic the microenvironment of the airway, and can include controlled media flow and multiple cell layers including human primary epithelium, fibroblasts, and endothelial cells (Sellgren et al., 2014; Benam et al., 2016). These in vitro systems successfully mimic the microenvironment of an airway, but are designed for small scale and high throughput applications. In contrast tHLOs are an in vivo system that may be more appropriate for low-throughput disease modeling or for pre-clinical drug testing, which has a great unmet need for better models that more accurately mimic human tissue in both healthy and diseased states in order to improve prediction of drug efficacy. This is particularly true for diseases that affect the lung, in part because commonly used animal models do not faithfully recapitulate several key aspects of the human disease (Moore and Hogaboam, 2008). Moreover, there is generally a poor track record of accurately predicting which drugs will work in humans based on pre-clinical animal models (Ruggeri et al., 2014; Mak et al., 2014), as up to 80% of drugs that pass pre-clinical tests fail in humans (Perrin, 2014). A prime example of this is in lung disease where many therapies have shown benefit in mouse models, but only 2 of these have shown benefit in humans (Myllärniemi and Kaarteenaho, 2015).
It is interesting to speculate that tHLOs will have utility as a novel model to study complex tissue-tissue interactions in airway homeostasis or disease. For example, since tHLOs have the potential to interact with the host immune system, and since the epithelium possesses diverse cell types including club and goblet cells, it may be possible to model inflammatory insults resulting in goblet cell hyperplasia. Future directions will be aimed at exploiting this new in vivo model of the human airway to better understand disease and to improve human health.
Human ES line UM63-1 (NIH registry #0277) was obtained from the University of Michigan and human ES line H9 (NIH registry #0062) and H1 (NIH registry #0043) was obtained from the WiCell Research Institute. All experiments using human ES cells were approved by the University of Michigan Human Pluripotent Stem Cell Research Oversight Committee. ES cell lines are routinely karyotyped to ensure normal karyotype, at which time the sex chromosomes of each line are confirmed (H9 - XX; H1 - XY; UM63-1 - XX). Monthly mycoplasma monitoring is conducted on all cell lines using the MycoAlert Mycoplasma Detection Kit (Lonza). Human tissue: Normal, de-identified human fetal lung tissue was obtained from the University of Washington Laboratory of Developmental Biology. Normal, de-identified human adult lung tissue was obtained from deceased organ donors through the Gift of Life, Michigan. All research with human tissue was approved by the University of Michigan institutional review board. Animal use: All mouse work was reviewed and approved by the University of Michigan Committee on Use and Care of Animals.
Stem cells were maintained on hESC-qualified Matrigel (Corning, Cat#: 354277) in mTesR1 medium (STEM CELL Technologies). HESCs were passaged as previously described (Spence et al., 2011). HLOs were generated as previously described (Dye et al., 2015). All HLOs imaged and quantifications of tHLOs were derived from UM63-1 unless otherwise stated.
Mice were anesthetized using 2% isofluorane. The left flank was sterilized using Chlorhexidine and isopropyl alcohol. A left flank incision was used to expose the kidney. 35d HLOs were manually placed in a subcapsular pocket of the kidney of male 7–10 week old NOD-scid IL2Rgnull (NSG) mice using forceps. An intraperitoneal flush of Zosyn (100 mg/kg; Pfizer Inc.) was administered prior to closure in two layers. The mice were sacrificed and transplant retrieved after 4 weeks. Foregut spheroids mixed with 100% Matrigel were injected underneath the mouse kidney capsule using a flexible catheter and transplants were retrieved after 6 weeks. For omental transplants, the abdomen was prepped and a midline incision was used to expose the greater omentum. 65d HLOs were sutured into the greater omentum using non-absorbable suture. Transplants were retrieved after 12 weeks.
PLG scaffolds were generated as previously described (Blomeier et al., 2006). Briefly, 2.5 mg of 6% PLG and 75 mg of NaCl (250–425 µm diameter) were mixed and incubated at 37°C for 7 min and then set at room temperature for 6 min. The mixture was pressed into 2 mm thick, 5 mm wide cylinders at 1500 psi for 30 s. Pressed scaffolds were foamed at 800 psi CO2 for 16 hr. Foamed scaffolds can be stored in a dry environment for weeks. PLG scaffolds were leeched in ddH2O for two 1-hr washes to remove NaCl. The scaffolds were then washed in 70% EtOH for 2 min for sterilization prior to use in experiments and dried for 5 min. PLG scaffolds were flushed with 15 µL of cold hESC qualified Matrigel diluted in DMEM/F12 (dilution factor is lot dependent, Corning Cat#: 354277) and incubated at 37°C for 15 min. This step was repeated twice. Lung spheroids were mixed with 100% Matrigel (Corning, Cat#: 354234) and pipetted into the scaffold. The seeded scaffolds were incubated for 15 min at 37°C and then overlaid with HLO media (500 ng/mL FGF10 and 1% FBS in basal foregut media described in [Dye et al., 2015]). Scaffolds were cultured for 5 to 7 days in vitro with media being changed every other day. Scaffolds cultured with spheroids were removed from culture and were then immersed in Matrigel supplemented with 500 ng/mL FGF10, allowed to solidify for 5 min or were directly used for transplants. Mice were anesthetized and prepped as for omental transplants. The epididymal fat pads of male 7–10 week old NOD-scid IL2Rgnull (NSG) were exposed using a lower midline incision. Matrigel coated scaffolds were then placed along the epididymal blood vessels and covered with epididymal fat. An intraperitoneal flush of Zosyn (100 mg/kg; Pfizer Inc.) was administered after which the incision was closed in 2-layers using absorbable suture. Mice were sacrificed between 4 and 15 weeks post-transplant.
Vybrant DiO Cell-Labeling Solution (ThermoFisher Scientific) was used based on manufacture’s protocol. Briefly, spheroids were incubated with the dye (5 µL dye per 1 mL media) for 20 min at 37°C. Spheroids were washed in media two times and were ready to use and image.
For human tissue sections: Anatomically, we considered the upper airway to be anything above the terminal bronchioles in the lung. Analyses conducted on human adult airways were carried out on sections through the lower bronchi of the upper airway, defined by the lack of adjacent cartilage and pseudostratified, undulated epithelial architecture. Analysis of human fetal airways was carried out on sections through bronchi and/or bronchioles of the upper airway at a level where the adjacent cartilage was present. Immunostaining was carried out as previously described (Rockich et al., 2013). Antibody information and dilutions can be found in Table 2. All images and videos were taken on a Nikon A1 confocal microscope or an Olympus IX71 epifluorescent microscope. Imaris software was used to render Z-stack three-dimensional images.
ECAD+ tissue was counted as airways with or without NKX2.1. In Figure 2H, NKX2.1+ airway-like tissue within individual tHLOs were quantitated to determine if they possessed ciliated cells, club cells or goblet cells by co-immunostaining with NKX2.1, ACTTUB, CC10 and MUC5AC antibodies, respectively. Cell height was measured of the cells facing in toward a lumen of an airway stained with ECAD by using ImageJ software.
All immunofluorescence (IF) were done on at least three (n = 3) independent biological samples per experiment except for foregut spheroids injected into the kidney capsule. Only 1 out 3 transplanted foregut spheroids under the kidney capsule yielded retrievable tissue; therefore only 1 sample was used for the IF analysis. For the airway quantification and cell height quantification the error bars represented SEM while the long bar represented the average. Statistical differences were assessed with Prism software using multiple t tests.
Type 2 alveolar cells are stem cells in adult lungJournal of Clinical Investigation 123:3025–3036.https://doi.org/10.1172/JCI68782
Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigationAmerican Journal of Respiratory and Critical Care Medicine 186:866–876.https://doi.org/10.1164/rccm.201204-0754OC
Gene expression profiling in lung fibroblasts reveals new players in alveolarizationPhysiological Genomics 32:128–141.https://doi.org/10.1152/physiolgenomics.00108.2007
Dynamic regulation of platelet-derived growth factor receptor α expression in alveolar fibroblasts during realveolarizationAmerican Journal of Respiratory Cell and Molecular Biology 47:517–527.https://doi.org/10.1165/rcmb.2012-0030OC
Organoid models of human gastrointestinal development and diseaseGastroenterology 150:1098–1112.https://doi.org/10.1053/j.gastro.2015.12.042
Organoids as an in vitro model of human development and diseaseNature Cell Biology 18:246–254.https://doi.org/10.1038/ncb3312
Three-dimensional culture model to distinguish normal from malignant human bronchial epithelial cellsEuropean Respiratory Journal 42:1345–1356.https://doi.org/10.1183/09031936.00118812
Airway branching morphogenesis in three dimensional cultureRespiratory Research 11:162.https://doi.org/10.1186/1465-9921-11-162
Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrixThe Annals of Thoracic Surgery 98:1721–1729.https://doi.org/10.1016/j.athoracsur.2014.05.080
PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetesTissue Engineering Part A 19:1465–1475.https://doi.org/10.1089/ten.tea.2012.0643
Enhancing human islet transplantation by localized release of trophic factors from PLG scaffoldsAmerican Journal of Transplantation 14:1523–1532.https://doi.org/10.1111/ajt.12742
Modeling mouse and human development using organoid culturesDevelopment 142:3113–3125.https://doi.org/10.1242/dev.118570
Human stem cell-based disease modeling: prospects and challengesCurrent Opinion in Cell Biology 37:84–90.https://doi.org/10.1016/j.ceb.2015.10.007
Expression of seven stem-cell-associated markers in human airway biopsy specimens obtained via fiberoptic bronchoscopyJournal of Experimental & Clinical Cancer Research 32:28.https://doi.org/10.1186/1756-9966-32-28
Lost in translation: animal models and clinical trials in cancer treatmentAmerican Journal of Translational Research 6:114–118.
Cell number and distribution in human and rat airwaysAmerican Journal of Respiratory Cell and Molecular Biology 10:613–624.https://doi.org/10.1165/ajrcmb.10.6.8003339
Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteineEuropean Clinical Respiratory Journal 2:26385.https://doi.org/10.3402/ecrj.v2.26385
Revascularization of transplanted pancreatic islets and role of the transplantation siteClinical and Developmental Immunology 2013:352315.https://doi.org/10.1155/2013/352315
Development and application of human adult stem or progenitor cell organoidsNature Reviews Nephrology 11:546–554.https://doi.org/10.1038/nrneph.2015.118
An in vivo model of human small intestine using pluripotent stem cellsNature Medicine 20:1310–1314.https://doi.org/10.1038/nm.3737
Janet RossantReviewing Editor; University of Toronto, Canada
In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.
Thank you for submitting your article "A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids" for consideration by eLife. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Janet Rossant as the Senior Editor. The reviewers have opted to remain anonymous.
The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.
In this research advance, building on their previous generation of lung organoids from human pluripotent cells, the authors have described a bioengineering approach to derive airway epithelial cell structures in vivo using scaffolds and iPS derived cells. Using a combination of organoid culture with matrigel and scaffold, the layered epithelium they achieve in vivo closely parallels human airway. The imaging and especially the polarity and organization of the cell types they have achieved is quite remarkable. This technique, if as reproducible and efficient as reported, could advance the field for the study of lung disease.
The main concern raised by the reviewers was around the reproducibility of the process and the quantitation of the extent of the differentiated structures produced. There is still wide variability in success for each transplant. What parameters are critical in determining efficiency? If this approach is to become a major tool for studying lung function and lung disease, the robustness with which the complex structures can be produced in different assays and using different starting cell lines is key.
The authors are requested to consider these issues and address them as outlined in the reviewers' comments below:
A major concern is that the overall reproducibility of the PLG technique is not clear. For example, it is not clear if every region of NKX2.1+,ECAD+ epithelium stained at 8 weeks post-transplant was differentiated as airway, or if differentiation was more patchy. Please quantify appropriately to clarify this point. In addition, 3x 15 week transplants are listed in Table 1 as showing NKX2.1+ regions with airway-like differentiation. Were these identical to the 8 week transplants? Two different cell lines are listed as being used in Table 1, were the results identical between them?
Similarly, was the airway epithelium obtained at 8-15 weeks post-transplant always arranged in tubes as shown in Figure 2F?
In general quantitation is appropriate and well described (although as noted above the origin of the samples scored is not shown e.g. all H9, or all UM63-1, or a mixture? 8 weeks or 15 weeks?) e.g. cell height of airway epithelium Figure 2B.
However, the quantitation of the secretory cell phenotype is missing (Figure 3). It may be difficult to quantitate accurately due to the low numbers of these cell types in the human airways. At the very least the numbers of samples in which CC10+, MUC5AC+ and PLUNC+ cells can be identified should be shown.
Related to this point, how are the fetal airways classified as upper or lower? And in which region of the adult airways are the images of secretory cells shown? e.g. mid-size bro.https://doi.org/10.7554/eLife.19732.022
- Briana R Dye
- Alyssa J Miller
- Alyssa J Miller
- Jason R Spence
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
JRS is supported by the NIH-NHLBI (R01 HL119215). AJM is supported by the NIH Cellular and Molecular Biology training grant at Michigan (T32 GM007315), and by the Tissue Engineering and Regeneration Training Grant (DE00007057-40). BRD is supported by a Graduate Fellowship from the University of Michigan Rackham graduate school. The University of Washington Laboratory of Developmental Biology was supported by NIH Award Number 5R24HD000836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.
Animal experimentation: All work using human pluripotent stem cells was approved by the University of Michigan Human Pluiripotent Stem Cell Research Oversight Committee (HPSCRO, application #1054). All human tissue used in this work was falls under NIH Exemption 4. The tissue was not obtained from living individuals, and was de-identified. Since this work falls under NIH Exemption 4, it was given a "not regulated" status by the University of Michigan IRB (protocol # HUM00093465 and HUM00105750). All animal experiments were approved by the University of Michigan Institutional Animal Care and Use Committee (IACUC; protocol # PRO00006609).
- Janet Rossant, Reviewing Editor, University of Toronto, Canada
© 2016, Dye et al
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.